WPRIM Management System> DCMS> The Korean Journal of Hepatology> 2009> 15

Volume: 15

1. The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease. Page:59—69
2. Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, lamivudine-resistant chronic hepatitis B patients. Page:52—58
3. The usefulness of transient elastography to diagnose cirrhosis in patients with alcoholic liver disease. Page:42—51
4. Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea. Page:25—41
5. Inhibition of in vitro hepatitis B virus replication by lentivirus-mediated short-hairpin RNA against HBx. Page:15—24
6. Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection. Page:7—14
7. Inhibition of hepatitis B virus replication by RNA interference. Page:1—6
8. Primary angiosarcoma of the liver. Page:216—221
9. Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C. Page:209—215
10. A case of liver metastasis of gastric hepatoid adenocarcinoma. Page:201—208
11. A case of hypervascular hyperplastic nodules mimicking hepatocellular carcinoma in alcoholic liver cirrhosis. Page:193—200
12. Long-term clevudine therapy in nucleos(t)ide-naive and lamivudine-experienced patients with hepatitis B virus-related chronic liver diseases. Page:179—192
13. Comparison of lamivudine-induced HBsAg loss rate according to age in children with chronic hepatitis B. Page:168—178
14. Clinical features of hepatic tuberculosis in biopsy-proven cases. Page:159—167
15. Analysis of the clinical characteristics and prognostic factors of ruptured hepatocellular carcinoma. Page:148—158
16. Distribution of hepatitis B virus genotypes in Korea. Page:140—147
17. Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation. Page:131—139
18. Pathology of nonalcoholic steatohepatitis. Page:122—130
19. Clevudine therapy in patients with chronic hepatitis B. Page:119—121
20. Current status of hepatic surgery in Korea. Page:S60—S64
21. Current status of hepatic surgery in Korea. Page:S60—S64
22. Current status of liver diseases in Korea: Hepatocellular carcinoma. Page:S50—S59
23. Current status of liver diseases in Korea: Hepatocellular carcinoma. Page:S50—S59
24. Current status of liver diseases in Korea: Liver cirrhosis. Page:S40—S49
25. Current status of liver diseases in Korea: Liver cirrhosis. Page:S40—S49
26. Current status of liver disease in Korea: Nonalcoholic fatty liver disease. Page:S34—S39
27. Current status of liver disease in Korea: Nonalcoholic fatty liver disease. Page:S34—S39
28. Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States. Page:106—110
29. Angiosarcoma. Page:101—105
30. Well differentiated hepatocellular carcinoma: ddmPathological diagnosis of needle biopsied liver tissue. Page:96—100
31. A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy. Page:90—95
32. A case of rhabdomyolysis during hospitalization for acute hepatitis A. Page:85—89
33. A case of hepatocellular carcinoma invading the gallbladder misdiagnosed as a primary gallbladder carcinoma. Page:80—84
34. Durability of a sustained virologic response in combination therapy with interferon/peginterferon and ribavirin for chronic hepatitis C. Page:70—79
35. Current status of liver diseases in Korea: Toxic and alcoholic liver diseases. Page:S29—S33
36. Current status of liver disease in Korea: Hepatitis C. Page:S25—S28
37. Current status of liver diseases in Korea: Hepatitis B. Page:S13—S24
38. Current status of liver diseases in Korea: Hepatitis A. Page:S7—S12
39. Role of cadherin-17 in hepatocellular carcinoma. Page:533—535
40. Neuroendocrine tumors of the liver. Page:528—532
41. Intrahepatic cholangiocarcinoma associated with Clonorchis sinensis infection. Page:524—527
42. A case of acute cholestatic hepatitis induced by Corydalis speciosa Max. Page:517—523
43. A case of primary hepatic epithelioid hemangioendothelioma with spontaneous rupture. Page:510—516
44. Two cases of toxic hepatitis caused by arrowroot juice. Page:504—509
45. A comparison of 24- vs. 48-week peginterferon plus ribavirin in patients with genotype 1 chronic hepatitis C. Page:496—503
46. Transcriptional profiling and Wnt signaling activation in proliferation of human hepatic stellate cells induced by PDGF-BB. Page:486—495
47. Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm. Page:474—485
48. Factors associated with liver stiffness in chronic liver disease. Page:464—473
49. Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease. Page:454—463
50. Clinical efficacy of entecavir therapy and factors associated with treatment response in naive chronic hepatitis B patients. Page:446—453
51. Epidemiology and clinical features of acute hepatitis A: from the domestic perspective. Page:438—445
52. Transient elastography, true or false?. Page:431—437
53. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma. Page:227—230
54. Epithelioid hemangioendothelioma. Page:222—226
55. Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis. Page:350—356
56. Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response. Page:338—349
57. Efficacy of 48-week clevudine therapy for chronic hepatitis B. Page:331—337
58. Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization. Page:320—330
59. Haplotype analysis and possible founder effect at the R778L mutation of the ATP7B gene in Korean patients with Wilson's disease. Page:309—319
60. Molecular targeting for treatment of advanced hepatocellular carcinoma. Page:299—308
61. Haplotype analysis at R778L mutation of ATP7B gene in Korean patients with Wilson disease. Page:295—298
62. Corrections: Distribution of hepatitis B virus genotypes in Korea. Page:424—424
63. Clinical outcomes and development of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients. Page:383—390
64. Peliosis hepatis. Page:379—382
65. Large liver cell change/dysplasia in hepatitis B virus-related liver cirrhosis. Page:375—378
66. A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C. Page:370—374
67. Four patients with hepatitis A presenting with fulminant hepatitis and acute renal failure and who underwent liver transplantation. Page:362—369
68. A case of metastatic hepatocellular carcinoma of the rib, treated by transcatheter arterial chemoembolization. Page:357—361